CHRNA7 and Alzheimer disease: While the contribution of α7nAChR to the astrocytic response to Aβ has not been thoroughly studied, the ability of α7nAChR ligands to modulate the astrocytic response to other inflammatory stimuli suggests that targeting α7nAChR might be beneficial in AD.